Cargando…
Evaluation of Pharmacokinetic Feasibility of Febuxostat/L-pyroglutamic Acid Cocrystals in Rats and Mice
Febuxostat (FBX), a selective xanthine oxidase inhibitor, belongs to BCS class II, showing low solubility and high permeability with a moderate F value (<49%). Recently, FBX/L-pyroglutamic acid cocrystal (FBX-PG) was developed with an improving 4-fold increase of FBX solubility. Nevertheless, the...
Autores principales: | Yu, Jeong-Eun, You, Byoung Hoon, Bae, Mingoo, Han, Seung Yon, Jung, Kiwon, Choi, Young Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459842/ https://www.ncbi.nlm.nih.gov/pubmed/37631381 http://dx.doi.org/10.3390/pharmaceutics15082167 |
Ejemplares similares
-
Improved Pharmacokinetic Feasibilities of Mirabegron-1,2-Ethanedisulfonic Acid, Mirabegron-1,5-Naphthalenedisulfonic Acid, and Mirabegron-L-Pyroglutamic Acid as Co-Amorphous Dispersions in Rats and Mice
por: Kim, Seo-Yeon, et al.
Publicado: (2023) -
Pharmacokinetic Feasibility of Stability-Enhanced Solid-State (SESS) Tenofovir Disoproxil Free Base Crystal
por: You, Byoung Hoon, et al.
Publicado: (2023) -
Effect of Water Extract of Mangosteen Pericarp on Donepezil Pharmacokinetics in Mice
por: Bae, Mingoo, et al.
Publicado: (2021) -
Molecular Mechanism of L-Pyroglutamic Acid Interaction with the Human Sour Receptor
por: Eom, Sanung, et al.
Publicado: (2023) -
Pharmacokinetics and pharmacodynamics of febuxostat under fasting conditions in healthy individuals
por: ZHANG, MEI, et al.
Publicado: (2014)